A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done.
about
Will there ever be a universal Staphylococcus aureus vaccine?Mechanisms of infective endocarditis: pathogen-host interaction and risk states.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Risk factors for morbidity and mortality of bloodstream infection in patients undergoing hemodialysis: a nested case-control study.Risk and prognosis of Staphylococcus aureus bacteremia among individuals with and without end-stage renal disease: a Danish, population-based cohort study.Methicillin-Resistant Staphylococcus aureus USA300 Latin American Variant in Patients Undergoing Hemodialysis and HIV Infected in a Hospital in Bogotá, Colombia.Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.Antibiotic resistance patterns of microorganisms isolated from nephrology and kidney transplant wards of a referral academic hospital.Intravascular catheter-related bloodstream infection.Preventing and treating inflammation: role of dialysis access management.Identifying and classifying bloodstream infections among hemodialysis patients.Vaccines for Staphylococcus aureus and Target Populations.Lysozyme Associated Liposomal Gentamicin Inhibits Bacterial Biofilm.Reduced pro-inflammatory responses to Staphylococcus aureus bloodstream infection and low prevalence of enterotoxin genes in isolates from patients on haemodialysis.Chitosan coupling makes microbial biofilms susceptible to antibiotics.Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review.
P2860
Q26824837-F3022673-F22D-4088-A256-D8DB8324B19AQ30317657-29D8EB54-21B8-4A5F-928C-A4C352C17EABQ34478074-A7973907-08CA-4B9A-A90D-F417FCC03E5EQ34968423-90534CF2-8958-4F7E-A8C7-D60F8906B9E1Q34976131-70191850-6212-4E92-A57D-9679CB4E6B19Q35810464-5099B2AD-722C-4C94-BB05-1343E470BF08Q35827804-DEB77128-A52B-4846-B2D3-4B252E003D2FQ35887127-0ED6DCD9-F2A1-401F-8F6E-D8548E73E55DQ36646727-CBD7DC02-351B-4BD0-AFEE-3815E0DD1CA4Q37248085-516A9D08-9DC3-4C78-AA7F-5B41B01B4522Q38050195-C8DB6B96-9252-4B9C-BEF7-3A26CD355612Q38099683-FC9C45AC-7558-463F-99B2-032E27BA6D8DQ38961271-55CFE8A7-E545-4055-BB28-F1C559E19A76Q40256475-7003B3B2-0A13-435C-9688-45AF4C8D0684Q40537414-9BDD2220-EA3C-41E1-BC8E-8472FBC1A91EQ42863067-5F67A895-2D48-458B-A046-A3DB7DCBD54CQ47654030-000AD56D-7700-4211-B661-9BAE78C413FD
P2860
A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
A 12-year review of Staphyloco ...... atients: more work to be done.
@en
A 12-year review of Staphyloco ...... atients: more work to be done.
@nl
type
label
A 12-year review of Staphyloco ...... atients: more work to be done.
@en
A 12-year review of Staphyloco ...... atients: more work to be done.
@nl
prefLabel
A 12-year review of Staphyloco ...... atients: more work to be done.
@en
A 12-year review of Staphyloco ...... atients: more work to be done.
@nl
P2093
P1476
A 12-year review of Staphyloco ...... atients: more work to be done.
@en
P2093
F Fitzpatrick
H Humphreys
J O'Gorman
M M Morris-Downes
P J Conlon
R K Crowley
S F Fitzgerald
P304
P356
10.1016/J.JHIN.2011.06.015
P577
2011-11-01T00:00:00Z